Business Context and Reporting Period
Company: Assembly Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 6, 2015
Event: Exercise of underwriters' option in a public offering and announcement of the 2015 Annual Meeting.
Key Financial Metrics
- Additional Shares Issued: 833,333 shares of common stock.
- Offering Price: $13.50 per share.
- Gross Proceeds from Option Exercise: $11,249,995.
- Total Gross Proceeds (Updated): Approximately $86.2 million (increased from $75 million).
- Net Proceeds: Not specified; filing notes proceeds are before underwriting discounts, commissions, and offering expenses.
- Revenue, Profit, Cash Flow, Debt, Liquidity: The filing text does not provide a clear value for these operational metrics.
Material Changes
The primary material change is the increase in total capital raised from the public offering. The exercise of the underwriters' option increased the total gross proceeds from $75 million to approximately $86.2 million.
Outlook, Commentary, and Corporate Events
- Annual Meeting: The company intends to hold its 2015 Annual Meeting on May 28, 2015.
- Management Commentary: No additional strategic commentary or risk factors were disclosed in this specific filing beyond the transaction details.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses.
- Confirm the use of proceeds for the additional $11.25 million raised.
- Review the proxy statement for the May 28, 2015 Annual Meeting for governance updates.
- Check subsequent filings for the impact of the increased capital on the company's cash runway and operational milestones.